These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8569214

  • 1. Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
    Hashimoto J, Imai Y, Minami N, Munakata M, Abe K.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):548-54. PubMed ID: 8569214
    [Abstract] [Full Text] [Related]

  • 2. Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
    Okada H, Suzuki H, Kanno Y, Saruta T.
    J Cardiovasc Pharmacol; 1995 May; 25(5):847-52. PubMed ID: 7630164
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM, Phillips PA, Stephenson JM, Risvanis J, Rolls KA, Johnston CI.
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries.
    Chiba S, Tsukada M.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):393-5. PubMed ID: 1330628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
    Mimura Y, Ogura T, Yamauchi T, Otsuka F, Oishi T, Harada K, Hashimoto M, Ota Z.
    Acta Med Okayama; 1995 Aug 20; 49(4):187-94. PubMed ID: 7502678
    [Abstract] [Full Text] [Related]

  • 9. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y, Takayama S, Ren LM, Sawaki S, Inoue Y, Chiba S.
    J Pharmacol Exp Ther; 1992 Nov 20; 263(2):627-31. PubMed ID: 1331408
    [Abstract] [Full Text] [Related]

  • 10. Role of vasopressin on cardiovascular changes during hemorrhage in conscious rats.
    Fujisawa Y, Miyatake A, Hayashida Y, Aki Y, Kimura S, Tamaki T, Abe Y.
    Am J Physiol; 1994 Nov 20; 267(5 Pt 2):H1713-8. PubMed ID: 7977803
    [Abstract] [Full Text] [Related]

  • 11. Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats.
    Sampey DB, Burrell LM, Widdop RE.
    Am J Physiol; 1999 Mar 20; 276(3):R872-9. PubMed ID: 10070150
    [Abstract] [Full Text] [Related]

  • 12. Vascular responses to vasopressin antagonists in man and rat.
    Burrell LM, Phillips PA, Rolls KA, Buxton BF, Johnston CI, Liu JJ.
    Clin Sci (Lond); 1994 Oct 20; 87(4):389-95. PubMed ID: 7834989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M, Suzuki H, Murakami M, Matsumoto A, Ichihara A, Nakamoto H, Yamamura Y, Saruta T.
    Am J Physiol; 1993 Oct 20; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats.
    Nishikimi T, Kawano Y, Saito Y, Matsuoka H.
    J Cardiovasc Pharmacol; 1996 Feb 20; 27(2):275-82. PubMed ID: 8720428
    [Abstract] [Full Text] [Related]

  • 17. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    Naitoh M, Suzuki H, Murakami M, Matsumoto A, Arakawa K, Ichihara A, Nakamoto H, Oka K, Yamamura Y, Saruta T.
    Am J Physiol; 1994 Dec 20; 267(6 Pt 2):H2245-54. PubMed ID: 7810724
    [Abstract] [Full Text] [Related]

  • 18. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension.
    Crofton JT, Ota M, Share L.
    J Hypertens; 1993 Oct 20; 11(10):1031-8. PubMed ID: 8258666
    [Abstract] [Full Text] [Related]

  • 19. Organic osmolytes in rat renal inner medulla are modulated by vasopressin V1 and/or V2 antagonists.
    Nakanishi T, Yamauchi A, Nakahama H, Yamamura Y, Yamada Y, Orita Y, Fujiwara Y, Uyeda N, Takamitsu Y, Sugita M.
    Am J Physiol; 1994 Jul 20; 267(1 Pt 2):F146-52. PubMed ID: 8048555
    [Abstract] [Full Text] [Related]

  • 20. Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
    Okada H, Suzuki H, Kanno Y, Yamamura Y, Saruta T.
    Clin Sci (Lond); 1994 Apr 20; 86(4):399-404. PubMed ID: 8168333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.